LONDON, April 17, 2012 /PRNewswire/ --
Senior clinical executives from top pharmaceutical companies, including AstraZeneca, Sanofi, Shire and GSK, met recently at the US offices of Shire Pharmaceuticals to agree quality standards and define competencies for a global competition to recognise and encourage talented researchers in North and South America.
The US Clinical Researcher of the Year competition (http://www.usclinicalresearcher.com) provides professionals working within the clinical research fraternity an opportunity for personal development through a series of peer-mediated, competency-based exercises. It is partnered with and sponsored by the ACRP.
"There are very few opportunities for professionals to benchmark their skills within a protected environment, where the quality standards are established and judged by senior industry peers," notes Sean Morgan-Jones of organizers PharmaTimes. "The aims of the competition are three-fold. To provide a development opportunity for ambitious research professionals, to help organizations benchmark with their peers, and to deliver industry insights and learning."
Themes identified by the competition's Executive Steering Committee for the 2012 competition include risk-based monitoring and technology as a facilitator for patient recruitment. The committee's first task was to agree quality standards for the first phase of the competition, an online multiple-choice questionnaire based on ICH/GCP/FDA regulatory guidelines and ratified by lead examiners from ACRP. Susan Romberg, vice president of clinical operations for the Americas at competition sponsors PRA, is leading a sub-committee to develop the case study used in the second screening stages.
This year the qualifying score has been raised to 80%.
The finals and awards are on November 8, 2012, at the Executive Briefing Centre of competition sponsors and hosts, SAS, in Cary, No
|SOURCE Pharma Times|
Copyright©2010 PR Newswire.
All rights reserved